Medicare drug coverage faces an ominous spending outlook

Medicare Part D spending is surging after the Inflation Reduction Act capped patient costs at $2,000, with over 1 in 5 enrollees hitting the cap in 2025. The cost shift to the government threatens coverage and could force painful tradeoffs over the next decade.